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(p=0.055), quick stretch (p=0.007), and movement initiation
(p=0.002).
Conclusions: EMG data collected with this protocol can help
the clinician distinguish spastic from dystonic hypertonia.
D7
The relationship of secondary dystonia and
choreoathetosis with activity, participation and
quality of life measures in children with
dyskinetic cerebral palsy
E MONBALIU, P DE COCK, L MAILLEUX, E ORTIBUS,
K KLINGELS, H FEYS
KU Leuven, Leuven, Belgium
Background/Objectives: To date, little information is available as
to how, and to what extent dystonia and choreoathetosis affect
the functional activity, participation and quality of life in chil-
dren with dyskinetic cerebral palsy (CP). Yet, the primary goal
of therapeutic interventions is to enhance the child’s ability to
perform activities in the context of daily life, which are closely
related with participation and quality of life (QOL). Therefore,
knowledge of the impact of secondary dystonia and choreoathe-
tosis on the different levels of the ICF model and QOL is
important to guide treatment interventions. The objective of
this study was to determine the relationship between dystonia
and choreoathetosis and the level of activity, participation and
quality of life in children with dyskinetic CP.
Design: cohort study (correlational).
Participants and setting: This study included 54 participants
with dyskinetic CP (mean age 14y 6mo, SD 4y 2mo),
recruited from five Belgian Flemish special education schools
for children with motor disabilities.
Methods: Dystonia and choreoathetosis were measured with
the Dyskinesia Impairment Scale (DIS). Activity measures
included the Gross Motor Function Measurement (GMFM-
88), the Functional Mobility Scale (FMS), the Jebsen-
Taylor Test of Hand Function (JTT), and the Abilhand-
Kids Questionnaire (ABIL-K). The Life Habits Kids (LIFE-
H) was used as a measure for social participation. For qual-
ity of life, the Quality of Life Questionnaire for children
with CP (CP-QOL) was applied. Spearman’s rank correla-
tion (rs) was used to assess the relationship between both
motor disorders and the activity, participation and quality of
life measures.
Results: Significant moderate to good correlation coefficients
were found between dystonia and the activity scales with rs
varying between 0.64 and 0.71. Fair correlations coeffi-
cients were found with the LIFE-H (rs=0.42) and the CP-
QOL (rs=0.32). For choreoathetosis, no or only weak
relationship was found with the activity, participation and
quality of life scales.
Conclusions: This study is the first to examine the relationship
between dystonia and choreoathetosis in children with dyski-
netic CP and their activity abilities, participation and quality
of life. A strong relationship was found between the presence
of dystonia and activity scales. Similarly, considerable associa-
tion was found with participation and quality of life scale,
although into a lesser extent. For choreoathetosis, little or no
relationship was found. These findings seem to suggest that it
might be most crucial to focus on dystonia reducing interven-
tion studies.
D8
Muscle strength after botulinum neurotoxin
injection in children with cerebral palsy
MN EEK, M P AHLMAN, K HIMMELMANN, B ASKLJUNG
Regional Rehabilitation Centre, Gothenburg, Sweden
Background/Objectives: Spasticity is a common problem in chil-
dren with cerebral palsy (CP), which can affect motor devel-
opment. Botulinum neurotoxin injection (Btx) can be used to
reduce spasticity. The drug effect is maximal after 4 to
6 weeks and lasts about 3 months. Muscle weakness has been
reported, but we have found only one study that has measured
muscle strength (Bjornson et al 2007), showing an increase
24 weeks after injection. The reports are conflicting and it is
not fully known how Btx affects voluntary muscle strength.
Muscle weakness is common in children with CP and has
been shown to correlate with walking ability (Eek et al 2008).
The aim of the study was to follow muscle strength, before
and after injection with Btx, in children with CP.
Design: Prospective cohort study.
Participants and setting: Children were recruited consecutively
from the spasticity clinic at the Regional Rehabilitation Cen-
tre in Gothenburg, Sweden. Twenty-three children with
spastic CP, able to walk without support, were recruited.
Three were lost to follow up, resulting in 20 children
included, eight girls and 12 boys, 4 to 13 years old (mean
7.7). Sixteen children had unilateral and four bilateral
involvement. Btx injection was made in the gastrocnemius
muscle in 24 legs.
Methods: Measurement of muscle strength in plantar flexors
was made with a handheld device. Lever arm was measured
with a tape measure, torque was calculated and normalized to
body weight (Nm/Kg). Muscle strength was compared before
Btx, at peak effect and when Btx has leveled off. Not treated
muscles served as control to treated muscle groups. Gait
Figure 5: Distribution of muscle responses by subject group.
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